Anti-igf-ir antibodies and uses thereof

Details Anti-igf-ir antibodies and uses thereof Anti-igf-ir antibodies and uses thereof

2005-07-27

2010-12-21

Huynh, Phuong (Department: 1644)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

C424S141100, C424S143100, C435S070210, C530S387100, C530S388100, C530S388220

Reexamination Certificate

active

07854930

ABSTRACT:
The present invention relates to novel antibodies capable of binding specifically to the human insulin-like growth factor I receptor IGF-IR and/or capable of specifically inhibiting the tyrosine kinase activity of said IGF-IR, especially monoclonal antibodies of murine, chimeric and humanized origin, as well as the amino acid and nucleic acid sequences coding for these antibodies. The invention likewise comprises the use of these antibodies as a medicament for the prophylactic and/or therapeutic treatment of cancers overexpressing IGF-IR or any pathology connected with the overexpression of said receptor as well as in processes or kits for diagnosis of illnesses connected with the overexpression of the IGF-IR. The invention finally comprises products and/or compositions comprising such antibodies in combination with anti-EGFR antibodies and/or anti-VEGF antibodies and/or antibodies directed against other growth factors involved in tumor progression or metastasis and/or compounds and/or anti-cancer agents or agents conjugated with toxins and their use for the prevention and/or the treatment of certain cancers.

REFERENCES:
patent: 5891996 (1999-04-01), Mateo de Acosta del Rio et al.
patent: 7241444 (2007-07-01), Goetsch et al.
patent: 7553485 (2009-06-01), Goetsch et al.
patent: 2008/0063639 (2008-03-01), Goetsch et al.
patent: 2008/0193445 (2008-08-01), Goetsch et al.
patent: 2008/0286198 (2008-11-01), Goetsch et al.
patent: 2009/0265797 (2009-10-01), Goetsch et al.
patent: 2009/0324600 (2009-12-01), Haeuw et al.
patent: WO-02/053596 (2002-07-01), None
patent: WO-03/059951 (2003-07-01), None
patent: WO-03/100008 (2003-12-01), None
patent: WO-03/106621 (2003-12-01), None
Rodeck et al, J Cell Biochem 35(4): 315-20, Dec. 1987.
Li S-L et al., Cancer Immunology and Immunotherapy, Berlin, DE, vol. 49, No. 4/5, Jul. 2000, pp. 243-252.
Sell et al., Proc. Natl. Acad. Sci. USA, vol. 90, Dec. 1993, pp. 11217-11221.
Valentinis et al., The Journal of Biological Chemistry, vol. 274, No. 18, Apr. 30, 1999, pp. 12423-12430.
Sell et al., Molecular and Cellular Biology, vol. 14, No. 6, Jun. 1994, pp. 3604-1612.
Morrione et al., Journal of Virology, vol. 69, No. 9, Sep. 1995, pp. 5300-5303.
Arteaga et al., Cancer Research, vol. 49, Nov. 15, 1989, pp. 6237-6241.
Coppola et al., Molecular and Cellular Biology, vol. 14, No. 7, Jul. 1994, pp. 4588-4595.
Jiang et al., Oncogene, vol. 18, 1999, pp. 6071-6077.
Burrow et al., Journal of Surgical Oncology, vol. 69, 1998, pp. 21-27.
Scotlandi et al., Cancer Research, vol. 58, Sep. 15, 1998, pp. 4127-4131.
Christiansen et al., Proc. Natl. Acad. Sci. USA, vol. 88, Jan. 1991, pp. 248-252.
Pandini et al., The Journal of Biological Chemistry, vol. 277, No. 42, Oct. 18, 2002, pp. 39684-39695.
Phy et al., The Journal of clinical Endocrinology & Metabolism, vol. 89, No. 7, 2004, pp. 3561-3566.
Laviola et al., J. Clin. Invest., vol. 99, No. 5, Mar. 1997, pp. 830-837.
Nakae et al., Endocrine Reviews, vol. 22, No. 6, Dec. 2001, pp. 818-835.
Koval et al., Biochem. J., vol. 330, 1998, pp. 923-932.
Cheatham et al., vol. 16, No. 2, Apr. 1995, pp. 117-142.
Mosthaf et al., The EMBO Journal, vol. 9, No. 8, 1990, pp. 2409-2413.
Frasca et al., Molecular and Cellular Biology, vol. 19, No. 5, May 1999, pp. 3278-3288.
Seely et al., Endocrinology, vol. 136, No. 4, 1995, pp. 1635-1641.
Bailyes et al., Biochem. J., vol. 327, 1997, pp. 209-215.
Sciacca et al., Oncogene, vol. 18, 1998, pp. 2471-2479.
Vella et al., J. Clin. Pathol: Mol. Pathol., vol. 54, 2001, pp. 121-125.
Pandini et al., Clinical Cancer Research, vol. 5, Jul. 1999, pp. 1935-1944.
Smith et al., Advances in Applied Mathematics, vol. 2, 1981, pp. 482-489.
Needleman et al., J. Mol. Biol., vol. 48, 1970, pp. 443-453.
Pearson et al., Proc. Natl. Acad. Sci. USA, vol. 85, Apr. 1988, pp. 2444-2448.
Kohler et al., Nature, vol. 256, Aug. 7, 1975, pp. 495-497.
Tatusova et al., FEMS Microbiology Letters, vol. 174, 1999, pp. 247-250.
Verhoeyen et al., BioEssays, vol. 8, No. 2, Feb./Mar. 1998, pp. 74-78.
Singer et al., The Journal of Immunology, vol. 150, No. 7, Apr. 1, 1993, pp. 2844-2857.
Bebbington et al., Bio/Technology, vol. 10, Feb. 1992, pp. 169-175.
Albanell et al., Journals of the National Cancer Institute, vol. 93, No. 24, Dec. 19, 2001, pp. 1830-1832.
Soos et al., Biochem. J., vol. 270, 1990, pp. 383-390.
Ciardiello, Drugs, vol. 60, 2000, pp. 25-32.
Lu et al., Journal of the National Cancer Institute, vol. 93, No. 24, Dec. 19, 2001, pp. 1852-1857.
Wraight et al., Nature Biotechnology, vol. 18, May 2000, pp. 521-526.
Herbst et al., Seminars in Oncology, vol. 29, No. 1, Feb. 2002, pp. 27-36.
Baserga et al., Biochimica et Biophysica Acta, vol. 1332, 1997, pp. 105-126.
Baserga, Experimental Cell Research, vol. 253, 1999, pp. 1-6.
Li et al., Biochemical and Biophysical Research Communications, vol. 196, No. 1, Oct. 15, 1993, pp. 92-98.
Prisco et al., Horm. Metab. Res., vol. 31, 1999, pp. 80-89.
DeAngelis et al., Journal of Cellular Physiology, vol. 164, 1995, pp. 214-221.
Zia et al., Journal of Cellular Biochemistry Supplement, vol. 24, 1996, pp. 269-275.
Salomon et al., Critical Reviews in Oncology/Hematology, vol. 19, 1995, 183-232.
Grothey et al., J. Cancer Res. Clin. Oncol., vol. 125, 1999, pp. 166-173.
Hakam et al., Human Pathology, vol. 30, No. 10, Oct. 1999, pp. 1128-1133.
Railo et al., European Journal of Cancer, vol. 30A, No. 3, 1994, pp. 307-311.
Happerfield et al., Journal of Pathology, vol. 183, 1997, pp. 412-417.
Carter, Nature, vol. 1, Nov. 2001, pp. 118-129.
Hortobagyi, Seminars in Oncology, vol. 28, No. 6, Dec. 2001, pp. 43-47.
Christiansen et al., Proc. Natl. Acad. Sci. USA, vol. 88, Jan. 1991, pp. 249-252.
Avruch, Molecular and Cellular Biochemistry, vol. 182, 1998, pp. 31-48.
White, Molecular and Cellular Biochemistry, vol. 182, 1998, pp. 3-11.
Roth et al., Cold Spring Harbor Symposia on Quantitative Biology, vol. 53, 1988, pp. 537-543.
Sasaoka et al. Endocrinology, vol. 137, No. 10, 1996, pp. 4427-4434.
Dupont et al., Horm. Res., vol. 55, 2001, pp. 22-26.
De Meyts et al., Annals New York Academy of Sciences, 1995, pp. 388-401.
Singh et al., Journal of Clinical Ligand Assay, vol. 23, No. 3, Fall 2000, pp. 214-232.
Kido et al., Journal of Clinical Endocrinology & Metabolism, vol. 86, No. 3, 2001, pp. 972-979.
Moller et al., Molecular Endocrinology, vol. 3, No. 8, 1989, pp. 1263-1269.
DeChiara et al., Nature, vol. 345, May 3, 1990, pp. 78-80.
Louvi et al., Developmental Biology, vol. 189, 1997, pp. 33-48.
Kasuya et al., Biochemistry, vol. 32, 1993, pp. 13531-13536.
Belfiore et al., Biochimie, vol. 81, 1999, pp. 403-407.
Jones et al., Nature, vol. 321, May 29, 1986, pp. 522-525.
Verhoeyen et al., Science, vol. 239, pp. 1534-1536; 1988.
Riechmann et al., Nature, vol. 332, Mar. 24, 1988, pp. 323-327.
Krejcarek et al., Biochemical and Biophysical Research Communications, vol. 77, No. 2, 1977, pp. 581-585.
Brechbiel et al., Bioconjugate Chem., vol. 2, 1991, pp. 187-194.
Gansow, Nucl. Med. Biol., vol. 18, No. 4., 1991, pp. 369-381.
Gansow et al., Cancer Imaging with Radiolabeled Antibodies, 1990, pp. 153-171.
Meares et al., Analytical Biochemistry, vol. 142, 1984, pp. 68-78.
Mountain et al., Biotechnology and Genetic Engineering Reviews, vol. 10, Dec. 1992, pp. 1-142.

Affiliated with

Also associated with

Rating

Anti-igf-ir antibodies and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-igf-ir antibodies and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-igf-ir antibodies and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4180391